The evidence, or lack therefore, is Schedule 13G.
Post# of 72445
(Total Views: 341)
Posted On: 03/21/2018 3:27:27 PM
The evidence, or lack therefore, is Schedule 13G. It tells us that Aspire is holding less than 5% (~7.25M) shares.
Scenario #1 - Let's assume Aspire is long and holding the first 7M shares sold to them. After that and in order to stay under 5%, they have to sell all shares immediately acquired from Leo.
Scenario #2 - Aspire has been selling consistently, which I believe it's their MO. They made money because they acquired the shares at a discount.
Scenario #3 - Aspire has been selling for the past four years, but decided to hold the recently acquired shares. It's possible but not likely.
IMO scenario #2 explains the constant selling pressure the best.
Scenario #1 - Let's assume Aspire is long and holding the first 7M shares sold to them. After that and in order to stay under 5%, they have to sell all shares immediately acquired from Leo.
Scenario #2 - Aspire has been selling consistently, which I believe it's their MO. They made money because they acquired the shares at a discount.
Scenario #3 - Aspire has been selling for the past four years, but decided to hold the recently acquired shares. It's possible but not likely.
IMO scenario #2 explains the constant selling pressure the best.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
